DJIA 16,503.32 103.65 0.63%
NASDAQ 4,385.88 69.81 1.62%
S&P 500 1,927.42 23.41 1.23%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

54.86 0.81 (1.49%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MRK $54.85 1.48%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $54.57
Previous Close $54.05
Daily Range $54.32 - $54.74
52-Week Range $44.62 - $61.33
Market Cap $158.2B
P/E Ratio 28.45
Dividend (Yield) $1.76 (3.3%)
Ex-Dividend Date
Dividend Pay Date
Volume 5,473,318
Average Daily Volume 10,671,636
Current FY EPS $3.48





Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website:

News & Commentary

This Drug Could Outsell Medical Marijuana

Three top motley fool analysts weigh in on drugs from Gilead Sciences, Biogen, Bristol-Myers, and Merck that could be bigger sellers than medical marijuana.

Gilead Sciences: Clear The Dockets And Settle With Merck Already

Will GlaxoSmithKline (GSK) Earnings Suffer on China Probe? - Analyst Blog

PetMed’s results hurt by shortened flea and tick season — seriously?

3 Stocks Reiterated As A Buy: INTC, MRK, JNJ

Dow Jones (DJIA) Today: Merck (MRK) Higher

Interesting April 2015 Stock Options for MRK

US FDA Accepts For Review A Biologics License Application For Merck And Sanofi Pasteur's Investigati

US FDA Accepts For Review A Biologics License Application For Merck And Sanofi Pasteur's Investigational Pediatric Hexavalent Vaccine

Confused, Bothered And Bewildered

Could This Game-Changing Drug Deliver $10 Billion in Sales Within Its First Year?

This recently approved drug has record-breaking potential and could top $10 billion in sales within its first year. Find out the name of this drug and the company behind it.

See More MRK News...

MRK's Top Competitors

MRK $54.86 (1.49%)
Current stock: MRK
JNJ $99.73 (0.53%)
Current stock: JNJ
NVS $88.01 (0.13%)
Current stock: NVS
RHHBY $36.23 (1.05%)
Current stock: RHHBY